Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
US FDA assigns new PDUFA date for BRILINTA (ticagrelor tablets)
-
European Commission approves nasal spray vaccine FLUENZ for the prevention of seasonal influenza in children
-
AstraZeneca PLC Fourth Quarter and Full Year Results 2010
-
AstraZeneca Replies To The US FDA Complete Response Letter For BRILINTA (Ticagrelor Tablets)
-
US Food and Drug Administration extend review timeline for vandetanib new drug application
-
AstraZeneca and Abbott end license agreement for the development of Certriad
-
AstraZeneca discontinues development of motavizumab for RSV prophylaxis indication
-
AstraZeneca receives complete response letter from US FDA for BRILINTA (ticagrelor tablets)
-
AstraZeneca PLC appoints new Non-Executive Director
-
Public believe China and India set to become World leaders for innovation, survey shows
Latest articles and press releases
All of our latest press releases and articles are available to explore
